EFFECTS OF PRIOR THERAPY ON PLASMA-LEVELS OF ADRIAMYCIN DURING SUBSEQUENT THERAPY

被引：0
作者：
GESSNER, T
ROBERT, J
BOLANOWSKA, W
HOERNI, B
DURAND, M
PREISLER, H
RUSTUM, J
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT MED ONCOL,BUFFALO,NY 14263
[2] FDN BERGONIE,SERV MED,BIOCHIM LAB,F-33076 BORDEAUX,FRANCE
来源：
JOURNAL OF MEDICINE | 1981年 / 12卷 / 2-3期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：183 / 193
页数：11
相关论文
共 17 条
  • [1] BACHUR NR, 1976, J MED CHEM, V19, P615
  • [2] BERN MM, 1978, CANCER, V42, P399, DOI 10.1002/1097-0142(197808)42:2<399::AID-CNCR2820420204>3.0.CO
  • [3] 2-5
  • [4] BYFIELD JE, 1977, CANCER TREAT REP, V61, P497
  • [5] CHLEBOWSKI RT, 1980, CANCER TREAT REP, V64, P47
  • [6] CRADOCK JC, 1973, ARCH INT PHARMACOD T, V202, P48
  • [7] GARNICK MB, 1979, CANCER RES, V39, P4105
  • [8] LIQUID-CHROMATOGRAPHIC ANALYSIS OF ADRIAMYCIN AND METABOLITES IN BIOLOGICAL-FLUIDS
    ISRAEL, M
    PEGG, WJ
    WILKINSON, PM
    GARNICK, MB
    [J]. JOURNAL OF LIQUID CHROMATOGRAPHY, 1978, 1 (06): : 795 - 809
  • [9] LEE YTN, 1980, CANCER, V45, P2231, DOI 10.1002/1097-0142(19800501)45:9<2231::AID-CNCR2820450902>3.0.CO
  • [10] 2-3
12